JAE-GEUN LEE

Dr. JAE-GEUN LEE

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2020 in European Heart Journal - Cardiovascular Pharmacotherapy
Verified
Journal Article
Closed access
PDF file
SJSeung-Jae Joo
Seung-Jae Joo
SKSong-Yi Kim
Song-Yi Kim
JCJoon-Hyouk Choi
Joon-Hyouk Choi
HPHyeung Keun Park
Hyeung Keun Park
JBJong Wook Beom
Jong Wook Beom
MJMyung Ho Jeong
Myung Ho Jeong
This observational study aimed to investigate the association between beta-blocker therapy and clinical outcomes in patients with acute myocardial infarction (AMI), especially with mid-range or preserved left ventricular systolic function. Among 13 624 patients enrolled in the Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH), 12 200 in-hospital survivors were selected. Patients with beta-blockers showed significantly lower 1-year major adverse cardiac events (MACE), which was a composite of cardiac death, MI, revascularization, and readmission due to heart failure [9.7 vs. 14.3/100 patient-year; hazard ratio (HR) 0.84, 95% confidence interval (CI) 0.72–0.97; P = 0.022). However, this association had a significant interaction with left ventricular ejection fraction (LVEF). Beta-blocker therapy at discharge was associated with lower 1-year MACE in patients with LVEF ≤40% (HR 0.63, 95% CI 0.48–0.81; P < 0.001), and 40% <LVEF < 50% (HR 0.69, 95% CI 0.51–0.94; P = 0.020), but not in patients with LVEF ≥50% (HR 1.16, 95% CI 0.91–1.48; P = 0.234). Beta-blocker therapy at discharge was associated with better 1-year clinical outcomes in patients with reduced or mid-range LVEF after AMI, but not in patients with preserved LVEF. These data suggested that the long-term beta-blocker therapy may be guided by LVEF.

1 May 2019 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
JLJAE-GEUN LEE
JAE-GEUN LEE
SJSeung-Jae Joo
Seung-Jae Joo

1 January 2011 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
JLJAE-GEUN LEE
JAE-GEUN LEE
DKDong Gu Kang
Dong Gu Kang
JYJung Re Yu
Jung Re Yu
YKYoung Ree Kim
Young Ree Kim
JKJin Soek Kim
Jin Soek Kim
DLDae Ho Lee
Dae Ho Lee
Lee JG, et al. Diabetes Metab J. 2011 Apr;35(2):149-158. https://doi.org/10.4093/dmj.2011.35.2.149

1 January 2012 in Chonnam Medical Journal
Verified
Journal Article
Open access
PDF file
JYJung Re Yu
Jung Re Yu
SLSang Ah Lee
Sang Ah Lee
JLJAE-GEUN LEE
JAE-GEUN LEE
GSGil Myeong Seong
Gil Myeong Seong
SKSeong Joo Ko
Seong Joo Ko
DLDae Ho Lee
Dae Ho Lee
Yu JR, et al. Chonnam Med J. 2012 Aug;48(2):108-115. http://dx.doi.org/10.4068/cmj.2012.48.2.108

1 January 2009 in Tuberculosis and Respiratory Diseases
Verified
Journal Article
Open access
PDF file
JCJaeyoung Chun
Jaeyoung Chun
JLJaechun Lee
Jaechun Lee
JBJaeseok Bae
Jaeseok Bae
MKMiyeon Kim
Miyeon Kim
JLJAE-GEUN LEE
JAE-GEUN LEE
KLKeun-Hwa Lee
Keun-Hwa Lee
Chun J, et al. Tuberc Respir Dis. 2009 Sep;67(3):239-243. http://dx.doi.org/10.4046/trd.2009.67.3.239

1 January 2012 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
JLJAE-GEUN LEE
JAE-GEUN LEE
SKSung Joo Koh
Sung Joo Koh
SYSo Yeon Yoo
So Yeon Yoo
JYJung Re Yu
Jung Re Yu
SLSang Ah Lee
Sang Ah Lee
DLDaeho Lee
Daeho Lee
Lee JG, et al. Korean J Intern Med. 2012 Sep;27(3):317-326. http://dx.doi.org/10.3904/kjim.2012.27.3.317